Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:44:01 UTC |
---|
Update Date | 2022-11-23 22:29:21 UTC |
---|
HMDB ID | HMDB0259807 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Viloxazine |
---|
Description | Viloxazine belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. Based on a literature review very few articles have been published on Viloxazine. This compound has been identified in human blood as reported by (PMID: 31557052 ). Viloxazine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Viloxazine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | InChI=1S/C13H19NO3/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11/h3-6,11,14H,2,7-10H2,1H3 |
---|
Synonyms | Value | Source |
---|
Astra brand OF viloxazine hydrochloride | MeSH | AstraZeneca brand OF viloxazine hydrochloride | MeSH | Viloxazine hydrochloride, (R)-isomer | MeSH | Viloxazine, (R)-isomer | MeSH | Emovit | MeSH | Viloxazine, (+-)-isomer | MeSH | Viloxazine, (S)-isomer | MeSH | Vivalan | MeSH | Viloxazine hydrochloride | MeSH | Viloxazine hydrochloride, (S)-isomer | MeSH | Viloxazine oxalate (1:1) | MeSH |
|
---|
Chemical Formula | C13H19NO3 |
---|
Average Molecular Weight | 237.299 |
---|
Monoisotopic Molecular Weight | 237.136493476 |
---|
IUPAC Name | 2-[(2-ethoxyphenoxy)methyl]morpholine |
---|
Traditional Name | viloxazine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC1=CC=CC=C1OCC1CNCCO1 |
---|
InChI Identifier | InChI=1S/C13H19NO3/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11/h3-6,11,14H,2,7-10H2,1H3 |
---|
InChI Key | YWPHCCPCQOJSGZ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenol ethers |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenol ethers |
---|
Alternative Parents | |
---|
Substituents | - Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Monocyclic benzene moiety
- Morpholine
- Oxazinane
- Dialkyl ether
- Secondary aliphatic amine
- Ether
- Oxacycle
- Secondary amine
- Organoheterocyclic compound
- Azacycle
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
viloxazine,1TMS,isomer #1 | CCOC1=CC=CC=C1OCC1CN([Si](C)(C)C)CCO1 | 1964.4 | Semi standard non polar | 33892256 | viloxazine,1TMS,isomer #1 | CCOC1=CC=CC=C1OCC1CN([Si](C)(C)C)CCO1 | 1953.3 | Standard non polar | 33892256 | viloxazine,1TMS,isomer #1 | CCOC1=CC=CC=C1OCC1CN([Si](C)(C)C)CCO1 | 2630.3 | Standard polar | 33892256 | viloxazine,1TBDMS,isomer #1 | CCOC1=CC=CC=C1OCC1CN([Si](C)(C)C(C)(C)C)CCO1 | 2192.6 | Semi standard non polar | 33892256 | viloxazine,1TBDMS,isomer #1 | CCOC1=CC=CC=C1OCC1CN([Si](C)(C)C(C)(C)C)CCO1 | 2161.3 | Standard non polar | 33892256 | viloxazine,1TBDMS,isomer #1 | CCOC1=CC=CC=C1OCC1CN([Si](C)(C)C(C)(C)C)CCO1 | 2785.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Viloxazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-052o-9630000000-de4a4c4b2490bdfb2e62 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Viloxazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Viloxazine 10V, Positive-QTOF | splash10-000i-0490000000-38ade0ceea39340d8cf4 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Viloxazine 20V, Positive-QTOF | splash10-0f9l-2920000000-41f5a6d5ec66b9e28825 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Viloxazine 40V, Positive-QTOF | splash10-0k96-9500000000-7e39764250d87e838280 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Viloxazine 10V, Negative-QTOF | splash10-000i-1690000000-3ac9495e347fdde90307 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Viloxazine 20V, Negative-QTOF | splash10-000i-2910000000-f5f7505276f04063b959 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Viloxazine 40V, Negative-QTOF | splash10-0a4i-4900000000-f1c02ad2cf31d248c444 | 2017-07-26 | Wishart Lab | View Spectrum |
|
---|